SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,561.89 -18.65
( -0.03%)

Global Indices

Nasdaq

51,370.81 -161.78
(-0.31%)

Dow Jones

7,725.73 -1.30
(-0.02%)

Hang Seng

66,308.10 794.11
(1.21%)

Nikkei 225

10,680.49 -24.77
(-0.23%)

Forex

USD-INR

95.73 0.08
(0.09%)

EUR-INR

109.20 -0.36
(-0.33%)

GBP-INR

127.12 -0.62
(-0.48%)

JPY-INR

0.61 0.00
(-0.28%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

P. H. Capital Ltd

Industry : Finance & Investments

BSE Code

ISIN Demat

Book Value()

500143

INE160F01013

191.8259391

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

335.22

EPS(TTM)

Face Value()

Div & Yield %

Back

mrf ltd

Concord Biotech consolidated net profit rises 32.84% in the June 2026 quarter

Aug 01,2026

Net profit of Concord Biotech rose 32.84% to Rs 58.53 crore in the quarter ended June 2026 as against Rs 44.06 crore during the previous quarter ended June 2025. Sales rose 26.23% to Rs 257.49 crore in the quarter ended June 2026 as against Rs 203.99 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	257.49	203.99	26
OPM %	31.99	30.10	-
PBDT	96.44	76.51	26
PBT	78.34	58.73	33
NP	58.53	44.06	33

73,561.89 -18.65 ( -0.03%)

51,370.81 -161.78 (-0.31%)

7,725.73 -1.30 (-0.02%)

66,308.10 794.11 (1.21%)

10,680.49 -24.77 (-0.23%)

95.73 0.08 (0.09%)

109.20 -0.36 (-0.33%)

127.12 -0.62 (-0.48%)

0.61 0.00 (-0.28%)